Navigation Links
Narrowest bridges of gold are also the strongest, study finds
Date:7/13/2011

BUFFALO, N.Y. -- At an atomic scale, the tiniest bridge of gold -- that made of a single atom -- is actually the strongest, according to new research by engineers at the University at Buffalo's Laboratory for Quantum Devices.

The counterintuitive finding is the result of experiments probing the characteristics of atomic-scale necks of gold that formed when the pointed, gold tip of a cantilever was pushed into a flat, gold surface. An examination of these tiny, gold bridges revealed that they were stiffest when they comprised just a single atom.

The study was published in June in Physical Review B by a trio of UB researchers: postdoctoral fellow Jason Armstrong and professors Susan Hua and Harsh Deep Chopra, all in UB's Department of Mechanical and Aerospace Engineering. Support for the work came from National Science Foundation grants No. DMR-0706074 and No. DMR-0964830.

As engineers look to build devices such as computer circuits with ever-smaller parts, it is critical to learn more about how tiny components comprising a single atom or a few atoms might behave. The physical properties of atomic-scale gadgets differ from those of larger, "bulk" counterparts.

"Everyday intuition would suggest that devices made of just a few atoms would be highly susceptible to mechanical forces," the team said. "This study finds, however, that the ability of the material to resist elastic deformation actually increases with decreasing size."

Another observation the team made while studying the tiny gold necks: abrupt atomic displacements that occur as the gold tip and surface are drawn apart are not arbitrary, but follow well-defined rules of crystallography. More scientific highlights of the work are summarized in the Physical Review Focus of the American Physical Society at http://focus.aps.org/story/v27/st24.

UB's Laboratory for Quantum Devices, led by Chopra and Hua, works on mapping the
'/>"/>

Contact: Charlotte Hsu
chsu22@buffalo.edu
716-645-4655
University at Buffalo
Source:Eurekalert  

Page: 1 2

Related biology technology :

1. Forward-Thinking Patient Recruitment Company Poised to Create Bridges Between Japanese Clinical R&D Industry and Global Clinical Trial Marketplace
2. Virginia Tech engineers investigate energy independent monitoring system for bridges
3. Chimerix Commences Phase 2 Clinical Study of CMX001 for Prevention of Adenovirus Disease in Pediatric and Adult Hematopoietic Stem Cell Transplant Patients
4. University of Dayton Study Overturns 250-Year-Old Belief About Effects of Age, Repeated Injury on Tissue Regeneration
5. InterMune Initiates Phase 3 ASCEND Study of Pirfenidone in IPF
6. Inovio Pharmaceuticals DNA Vaccine for Foot-and-Mouth Disease Generates Protective Neutralizing Antibodies in Second Large-Animal Study
7. Intarcia Presents Positive Phase 2 48-week Results From ITCA 650 Study at the American Diabetes Association 71st Scientific Sessions
8. New study: Even in flies, enriched learning drives need for sleep
9. Positive Results from Phase IIa Study Pave Way for Phase IIb Trial of AC-201 for the Treatment of Type II Diabetes
10. Morphotek®, Inc. Announces Initiation of MORAb-004 Phase II Study in Melanoma
11. Adeona Announces Positive Alzheimers Subgroup Analysis that Supports Additional Clinical Study of Proprietary Zinc-Based Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Narrowest bridges of gold are also the strongest, study finds
(Date:4/16/2015)... April 16, 2015 According to ... involving an outside source was ranked first among ... injuries related to lifting, pushing, pulling, holding, carrying, ... direct costs. The David Round Company takes statistics ... to working hard to develop and design equipment ...
(Date:4/16/2015)... , April 16, 2015  RegeneRx Biopharmaceuticals, ... announced its U.S. joint venture with G-treeBNT (ReGenTree ... phase 3 clinical trial for the orphan disorder, ... trial for dry eye syndrome (DES) in the ... eye drops, RGN-259/GBT201, this year.  Each of these ...
(Date:4/16/2015)... April 16, 2015  Scientists from Cleave Biosciences will ... the Horizon," at the American Association for Cancer Research ... on Sunday, April 19, 2015 from 3:15pm to ... of Biology, will present new in vivo and mechanism ... inhibitor of p97, a critical enzyme that controls various ...
(Date:4/16/2015)... Fairleigh Dickinson University ( FDU ... become the Executive Director of the Rothman Institute ... kick-off of the Initiative for Patient Centered Innovation ... under the Rothman Institute of Innovation and Entrepreneurship ... collaboration with FDU’s School of Pharmacy’s Center for ...
Breaking Biology Technology:The David Round Company Helps Companies Meet OSHA Standards by Combining Safety, Ergonomics, and Productivity 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5Cleave Biosciences to Participate in Special Session "New Drugs on the Horizon" at AACR Annual Meeting 2015 2Cleave Biosciences to Participate in Special Session "New Drugs on the Horizon" at AACR Annual Meeting 2015 3Dr. Joseph V. Gulfo Named Executive Director of Fairleigh Dickinson University’s Rothman Institute to Spearhead New Initiative for Patient-Centered Innovation (iPCI) 2Dr. Joseph V. Gulfo Named Executive Director of Fairleigh Dickinson University’s Rothman Institute to Spearhead New Initiative for Patient-Centered Innovation (iPCI) 3
... analysis results expected in Q3 2008 -, ... Therapeutics Inc.,(TSX:FXI) ("Fralex" or the "Company"), a ... today announced the,randomization of the 100th patient ... double-blind placebo-controlled randomized clinical trial,designed to assess ...
... Calif., March 10 AutoGenomics, a leader in,developing ... be among the leading healthcare and biotechnology companies ... that will be held at the,Boston Marriott Copley ... Executive Officer will present an overview of the,company, ...
... Nuclear Security Administration has awarded a $17 million cooperative ... Park to develop advanced simulations for commercial and defense ... center will focus on the behavior and reliability of ... of Excellence chosen by the NNSA. , About 35 ...
Cached Biology Technology:Fralex reaches 100th patient milestone in fibromyalgia study 2Fralex reaches 100th patient milestone in fibromyalgia study 3Purdue leads center to simulate behavior of micro-electromechanical systems 2Purdue leads center to simulate behavior of micro-electromechanical systems 3Purdue leads center to simulate behavior of micro-electromechanical systems 4
(Date:4/9/2015)... , April 9, 2015 Synaptics Inc. (NASDAQ: ... solutions, announced today that it will report financial results ... April 23, 2015, after the close of market. The ... and investors at 2:00 p.m. PT (5:00 p.m. ET), ... To participate on the live call, analysts and ...
(Date:4/2/2015)... According to preliminary estimates Fingerprint ... higher than 125 MSEK. This exceeds the guidance provided ... revenues for Q1 2015 would be in line with ... 2014. The operating result for the first quarter is ... report will as previously communicated be published on May ...
(Date:3/31/2015)... 31, 2015   Guidepoint , a leading global ... Post-Surgical Pain Management TRACKER, part of the Guidepoint ... in the medical device and therapeutics markets. The Post-Surgical ... treatment volumes, market share, and adoption rates across three ... joint surgery. The Post-Surgical Pain Management TRACKER ...
Breaking Biology News(10 mins):Synaptics to Report Third Quarter Results on April 23 2Fingerprint Cards Revises Revenues for Q1 2015 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3
... of the potential for microbes to prevent disease, researchers ... that mice exposed to common stomach bacteria were protected ... findings, reported in the journal Nature , support ... lack of exposure to parasites, bacteria and viruses in ...
... professors at Cold Spring Harbor Laboratory (CSHL) have succeeded ... proteins that enable genes to express themselves in specific ... Michael Q. Zhang, Ph.D. and Adrian R. Krainer, Ph.D., ... exploring a phenomenon that biologists and geneticists call RNA ...
... State-based life sciences research teams will progress to the ... grants competition, "Innovative Programs to Advance Health Research." A ... available in this competition. Funding in this competition will ... of research. Expert review of proposals in this ...
Cached Biology News:'Friendly' bacteria protect against type 1 diabetes, Yale researchers find 2CSHL team traces extensive networks regulating alternative RNA splicing 2CSHL team traces extensive networks regulating alternative RNA splicing 3CSHL team traces extensive networks regulating alternative RNA splicing 4Life Sciences Discovery Fund advances latest research proposals 2
...
... MBS Start up kit. Includes configured Laptop ... of 2 MultiBlock satellite thermal cyclers ... User friendly software. Store/track run ... heated lid. Outstanding uniformity. Advanced ...
Glycerokinase; from Bacillus stearothermophilus...
A compact, high-speed single tube reader unit designed for benchtop 2D barcode reading. The unit can be used with all of ABgene's 2D barcoded tubes, including the 2ml CryoCode tube....
Biology Products: